Osivax
Developer of vaccines to provide broad-spectrum protection against highly mutating respiratory viruses.
6
Funding Rounds
$37.4m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Al******* Le**** |
|
- | - |
| Al******* Le Ve** |
|
- | |
| Fl****** Ni***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Osivax has raised a total of $37.38m in funding over 6 rounds.
Key Insights:
- Osivax Series B Round, March 2025: $11m
- Osivax Grant (money), July 2020: $1.34m
- Osivax Grant (money), July 2020: $2.21m
- Osivax Series B round, July 2020: $13.27m
- Osivax Series A round, July 2019: $7.14m
- Osivax Seed round, June 2017: $2.41m
Osivax Series B Round, March 2025
$11m
Osivax Grant (money), July 2020
$1.34m
Osivax Grant (money), July 2020
$2.21m
Osivax Series B round, July 2020
$13.27m
Osivax Series A round, July 2019
$7.14m
Osivax Seed round, June 2017
$2.41m
Industries
Osivax is active in the following industries: